NIH-funded research Career grant

Effects of HIV prevention medication on gut bacteria and inflammation

Official title: Changes in Enteric Microbiota and Inflammation with HIV PrEP

Funded at Seattle Children's Hospital · NIH-10913543 · Data updated 2026-11-12

This study is looking at how starting PrEP for HIV might change the bacteria in your gut and affect inflammation, and it's for people who are beginning PrEP and want to understand its impact on their overall gut health.

More Microbiota research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$193,540
NIH project number5K08AI177080-02
Project IDNIH-10913543 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals aged 0-11 years who are starting HIV PrEP or are part of a control group not using PrEP.

Less likely to help

Patients who are not starting PrEP or are older than 11 years may not receive benefit from this research.

What this research studies

This research investigates how Pre-Exposure Prophylaxis (PrEP) for HIV affects the gut microbiome and inflammation levels in patients. By enrolling participants who are starting PrEP and comparing them to a control group not using PrEP, the study will collect blood and stool samples to analyze changes in gut bacteria and viruses over three months. Advanced metagenomic sequencing techniques will be used to identify and characterize these microbial communities and their interactions, providing insights into how PrEP may influence gut health and inflammation.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding of the gut health implications of HIV prevention strategies, potentially informing better treatment protocols.

How similar studies have gone: While the specific approach of this research is novel, there have been other studies exploring the relationship between gut microbiota and HIV treatments, indicating potential for meaningful findings.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Maust, Brandon Swartz — Seattle Children's Hospital
  • Study coordinator: Maust, Brandon Swartz

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.